In mantle cell lymphoma (MCL), STAT3 mutations, although rare, can lead to constitutive activation of the JAK/STAT pathway, promoting tumor cell survival, proliferation, and immune evasion (186). This evidence concerns the gene SOAT1 and mantle cell lymphoma.